Metis Global Partners LLC Lowers Stock Holdings in The Clorox Company (NYSE:CLX)

Metis Global Partners LLC cut its stake in shares of The Clorox Company (NYSE:CLX) by 5.6% during the fourth quarter, HoldingsChannel.com reports. The fund owned 5,743 shares of the company’s stock after selling 338 shares during the quarter. Metis Global Partners LLC’s holdings in Clorox were worth $819,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of CLX. Choreo LLC lifted its holdings in shares of Clorox by 12.8% in the 4th quarter. Choreo LLC now owns 5,741 shares of the company’s stock worth $819,000 after buying an additional 652 shares during the period. abrdn plc lifted its stake in Clorox by 20.1% in the fourth quarter. abrdn plc now owns 198,250 shares of the company’s stock worth $28,268,000 after acquiring an additional 33,135 shares during the period. International Assets Investment Management LLC grew its holdings in Clorox by 17,658.5% during the 4th quarter. International Assets Investment Management LLC now owns 484,453 shares of the company’s stock worth $69,078,000 after acquiring an additional 481,725 shares in the last quarter. Adage Capital Partners GP L.L.C. purchased a new position in Clorox during the 3rd quarter valued at about $6,605,000. Finally, Mission Wealth Management LP raised its holdings in shares of Clorox by 6.2% in the 4th quarter. Mission Wealth Management LP now owns 7,297 shares of the company’s stock valued at $1,040,000 after purchasing an additional 423 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.

Clorox Stock Up 0.8 %

NYSE:CLX opened at $141.56 on Friday. The company’s 50 day moving average is $147.74 and its two-hundred day moving average is $143.65. The company has a market cap of $17.58 billion, a PE ratio of 73.35, a P/E/G ratio of 2.13 and a beta of 0.44. The Clorox Company has a twelve month low of $114.68 and a twelve month high of $170.43. The company has a current ratio of 0.90, a quick ratio of 0.53 and a debt-to-equity ratio of 9.73.

Clorox (NYSE:CLX) last released its earnings results on Tuesday, April 30th. The company reported $1.71 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.33 by $0.38. The firm had revenue of $1.81 billion for the quarter, compared to the consensus estimate of $1.87 billion. Clorox had a return on equity of 302.49% and a net margin of 3.33%. The firm’s revenue was down 5.3% on a year-over-year basis. During the same period in the prior year, the firm earned $1.51 EPS. Analysts anticipate that The Clorox Company will post 5.83 EPS for the current year.

Clorox Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 10th. Stockholders of record on Wednesday, April 24th will be issued a $1.20 dividend. This represents a $4.80 annualized dividend and a dividend yield of 3.39%. The ex-dividend date of this dividend is Tuesday, April 23rd. Clorox’s dividend payout ratio (DPR) is currently 248.70%.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on CLX. Morgan Stanley reiterated an “equal weight” rating and set a $160.00 price objective on shares of Clorox in a research note on Tuesday, March 26th. JPMorgan Chase & Co. cut their price target on Clorox from $159.00 to $158.00 and set a “neutral” rating on the stock in a report on Wednesday, May 1st. Jefferies Financial Group upgraded Clorox from an “underperform” rating to a “hold” rating and set a $145.00 price objective for the company in a research note on Tuesday, March 26th. UBS Group cut their target price on Clorox from $164.00 to $159.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 1st. Finally, Citigroup decreased their price target on shares of Clorox from $155.00 to $150.00 and set a “neutral” rating for the company in a research report on Wednesday, May 1st. Four equities research analysts have rated the stock with a sell rating and thirteen have given a hold rating to the company’s stock. According to data from MarketBeat.com, Clorox has a consensus rating of “Hold” and an average target price of $146.43.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.